J. Alcocer‐Varela

发表

The autologous mixed lymphocyte reaction is not primarily due to xenoantigenic stimulation.

D. Alarcón-Segovia, A. Laffón, J. Alcocer‐Varela, 1983, Clinical immunology and immunopathology.

Mediators of inflammation are down‐regulated while apoptosis is up‐regulated in rheumatoid arthritis synovial tissue by polymerized collagen

J. Alcocer-Varela, J. Furuzawa-Carballeda, R. Rodríquez-Calderón, 2002, Clinical and experimental immunology.

Cytokine inhibitors in autoimmune disease.

J. Alcocer-Varela, A. L. Weckmann, J. Alcocer‐Varela, 1996, Seminars in arthritis and rheumatism.

A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans

R. Jonsson, A. Bolstad, A. Brookes, 2002, Nature Genetics.

Ubiquitination system and autoimmunity: the bridge towards the modulation of the immune response.

J. Alcocer-Varela, M. Diaz-Zamudio, D. Gómez-Martín, 2008, Autoimmunity reviews.

Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology.

J. Alcocer-Varela, M. Diaz-Zamudio, D. Gómez-Martín, 2011, Autoimmunity reviews.

Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus.

D. Alarcón-Segovia, J. Alcocer-Varela, A. Laffón, 1984, Clinical and experimental immunology.

Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus.

D. Alarcón-Segovia, J. Alcocer-Varela, M. Cardiel, 2000, Arthritis and rheumatism.

Plasmacytoid dendritic cells: key players in viral infections and autoimmune diseases.

J. Alcocer-Varela, D. Gómez-Martín, R. Soto-Solís, 2013, Seminars in arthritis and rheumatism.

Interleukin-2 and systemic lupus erythematosus—fifteen years later

J. Alcocer-Varela, J. Alcocer‐Varela, J. Crispín, 1998, Lupus.

Haplotype distribution of class II MHC genes in Mexican patients with systemic lupus erythematosus.

J. Alcocer-Varela, J. Yamamoto-Furusho, J. Granados, 1998, Scandinavian journal of rheumatology.

Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin

D. Alarcón-Segovia, J. Alcocer-Varela, F. Larrea, 2004, Lupus.

T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment.

D. Alarcón-Segovia, J. Alcocer-Varela, F. Larrea, 1986, Clinical immunology and immunopathology.

Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis.

D. Alarcón-Segovia, J. Alcocer-Varela, A. Duarte-Rojo, 2004, The Journal of rheumatology.

52 - Infection and Spondyloarthropathies

J. Alcocer-Varela, J. Acuña, J. Alcocer‐Varela, 2004 .

Differential ubiquitination in NETs regulates macrophage responses in systemic lupus erythematosus

J. Alcocer-Varela, C. Carmona-Rivera, M. Kaplan, 2018, Annals of the rheumatic diseases.

Add-on Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study

J. Alcocer-Varela, S. Valdés-Ferrer, Carlos A. Rodriguez-Osorio, 2017, Front. Immunol..

Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus

R. González-Amaro, J. Alcocer-Varela, C. Abud-Mendoza, 2017, Clinical and experimental immunology.

Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features

J. Alcocer-Varela, J. Torres-Ruiz, A. Zentella-Dehesa, 2019, Lupus.

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

D. Alarcón-Segovia, J. Alcocer-Varela, Y. Lévy, 1995, The Journal of experimental medicine.

In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity.

J. Alcocer-Varela, J. Wijdenes, Y. Richaud-Patin, 1994, Arthritis and rheumatism.

Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus.

P. Schur, D. Alarcón-Segovia, J. Alcocer-Varela, 1990, The Journal of clinical investigation.

T lymphocyte subsets, suppressor and contrasuppressor cell functions, and production of interleukin-2 in the peripheral blood of rheumatic fever patients and their apparently healthy siblings.

D. Alarcón-Segovia, J. Alcocer-Varela, M. Alarcón‐Riquelme, 1990, Clinical immunology and immunopathology.

Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus.

D. Alarcón-Segovia, J. Alcocer-Varela, E. Martínez‐Cordero, 1986, Clinical and experimental immunology.

Association analysis with microsatellite and SNP markers does not support the involvement of BCL-2 in systemic lupus erythematosus in Mexican and Swedish patients and their families

G. Sturfelt, L. Truedsson, D. Alarcón-Segovia, 2000, Genes and Immunity.

Protein phosphatase 2A B55ß limits CD8 T cell lifespan following cytokine withdrawal.

J. Alcocer-Varela, G. Tsokos, I. Madera-Salcedo, 2020, The Journal of clinical investigation.

Is damage in central nervous system due to inflammation?

J. Alcocer-Varela, A. Chavarría, J Alcocer-Varela, 2003, Autoimmunity reviews.

Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis.

J. Alcocer-Varela, A. Villa, F. J. van der Woude, 2003, Rheumatology.

Human Lupus Serum Induces Neutrophil-Mediated Organ Damage in Mice That Is Enabled by Mac-1 Deficiency

T. Mayadas, J. Alcocer-Varela, A. Lichtman, 2012, The Journal of Immunology.

That Is Enabled by Mac-1 Deficiency Neutrophil-Mediated Organ Damage in Mice Human Lupus Serum Induces

T. Mayadas, J. Alcocer-Varela, A. Lichtman, 2012 .

De Novo Donor-Specific HLA Antibody Development and Peripheral CD4+CD25high Cells in Kidney Transplant Recipients: A Place for Interaction?

J. Alcocer-Varela, J. C. Crispín, J. Alberú, 2012, Journal of transplantation.

Lymphopenia and autoimmunity: A double-edged sword.

J. Alcocer-Varela, M. Diaz-Zamudio, J. Merayo-Chalico, 2016, Human immunology.

Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus.

J. Alcocer-Varela, M. Cardiel, R. Ariza-Ariza, 1997, The Journal of rheumatology.

IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus.

J. Alcocer-Varela, A. Díaz-Alderete, M. I. Vargas-Rojas, 2004, Journal of autoimmunity.

The role myeloid dendritic cells play in the pathogenesis of systemic lupus erythematosus.

J. Alcocer-Varela, J. C. Crispín, J. Alcocer‐Varela, 2007, Autoimmunity reviews.

Quantitative and functional profiles of CD4+ lymphocyte subsets in systemic lupus erythematosus patients with lymphopenia

J. Alcocer-Varela, M. Diaz-Zamudio, D. Gómez-Martín, 2011, Clinical and experimental immunology.

Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance

J. Alcocer-Varela, Y. Richaud-Patin, M. I. Vargas-Rojas, 2008, Lupus.

Quantification of regulatory T cells in patients with systemic lupus erythematosus.

J. Alcocer-Varela, J. C. Crispín, Araceli Martínez, 2003, Journal of autoimmunity.

Cellular bases of the production of and response to interleukin-2 in man: role of autologous rosette-forming T-cell subsets defined with monoclonal antibodies.

D. Alarcón-Segovia, E. Fishbein, J. Alcocer‐Varela, 1983, Immunology.

Natural killer cell-mediated activity in mixed connective tissue disease and its response to induction by interleukin-2

R. González-Amaro, D. Alarcón-Segovia, J. Alcocer-Varela, 1984, Journal of Clinical Immunology.

Differences in the kinetics of the autologous mixed lymphocyte reaction between the various connective tissue diseases

D. Alarcón-Segovia, J. Alcocer-Varela, A. Laffón, 2004, Rheumatology International.

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.

D. Alarcón-Segovia, J. Alcocer-Varela, J. Alcocer‐Varela, 1982, The Journal of clinical investigation.

Adult-Onset Still Disease as the Cause of Fever of Unknown Origin

J. Alcocer-Varela, D. Martínez-Baños, J. Alcocer‐Varela, 2005, Medicine.

Differential T cell subsets and cytokine profile between steady-state and G-CSF-primed bone marrow and its association with graft-versus-host disease.

J. Alcocer-Varela, J. Merayo-Chalico, E. León-Rodríguez, 2017, Leukemia research.

A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus.

D. Alarcón-Segovia, J. Alcocer-Varela, F. Larrea, 1997, The Journal of clinical endocrinology and metabolism.

Amebic monocyte locomotion inhibitory factor peptide ameliorates inflammation in CIA mouse model by downregulation of cell adhesion, inflammation/chemotaxis, and matrix metalloproteinases genes

J. Alcocer-Varela, I. Alvarado-Cabrero, L. Teran, 2010, Inflammation Research.

Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility.

D. Alarcón-Segovia, J. Alcocer-Varela, J. Granados, 2001, Human immunology.

Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study

J. Alcocer-Varela, A. Barrera-Vargas, J. Torres-Ruiz, 2018, Lupus.

HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies.

D. Alarcón-Segovia, J. Alcocer-Varela, J. Granados, 1994, Annals of the rheumatic diseases.

The role of HLA-DR alleles and complotypes through the ethnic barrier in systemic lupus erythematosus in Mexicans

D. Alarcón-Segovia, J. Alcocer-Varela, J. Granados, 1996, Lupus.

Lack of association between the polymorphism at the heat-shock protein (HSP70-2) gene and systemic lupus erythematosus (SLE) in the Mexican Mestizo population

J. Alcocer-Varela, J. Granados, A. Arnaiz-Villena, 2000, Genes and Immunity.

Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients.

D. Alarcón-Segovia, J. Alcocer-Varela, J. Granados, 1995, Arthritis and rheumatism.

Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus.

J. Alcocer-Varela, J. Wijdenes, Y. Richaud-Patin, 1993, European cytokine network.

Lys63‐polyubiquitination by the E3 ligase casitas B‐lineage lymphoma‐b (Cbl‐b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus

J. Alcocer-Varela, D. Gómez-Martín, J. Romo-Tena, 2018, Clinical and experimental immunology.

Effect of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis

J. Alcocer-Varela, D. Kershenobich, M. Rojkind, 1990, Hepatology.

Description of a novel HLA-B35 (B*3514) allele found in a Mexican family of Nahua Aztec descent.

J. Alcocer-Varela, J. Granados, A. Arnaiz-Villena, 1996, Human immunology.

Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.

J. Malley, J. Alcocer-Varela, E. Shamim, 2002, Arthritis and rheumatism.

Follicular helper T cells poise immune responses to the development of autoimmune pathology.

J. Alcocer-Varela, M. Diaz-Zamudio, D. Gómez-Martín, 2011, Autoimmunity reviews.

Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus.

D. Alarcón-Segovia, J. Alcocer-Varela, J. Granados, 1997, Arthritis and rheumatism.

Phenotype and function of dendritic cells of patients with systemic lupus erythematosus.

J. Alcocer-Varela, A. Monsiváis-Urenda, M. I. Vargas-Rojas, 2012, Clinical immunology.

PPP2R2B hypermethylation causes acquired apoptosis deficiency in systemic autoimmune diseases.

J. Alcocer-Varela, O. Mutchinick, I. Madera-Salcedo, 2019, JCI insight.

PPP 2 R 2 B hypermethylation causes acquired apoptosis deficiency in systemic autoimmune diseases

J. Alcocer-Varela, O. Mutchinick, J. C. Crispín, 2019 .

T cell receptor-associated protein tyrosine kinases: the dynamics of tolerance regulation by phosphorylation and its role in systemic lupus erythematosus.

J. Alcocer-Varela, A. Barrera-Vargas, D. Gómez-Martín, 2014, Human immunology.

Rheumatologic manifestations of diabetes mellitus.

J. Alcocer-Varela, J. C. Crispín, J. Alcocer‐Varela, 2003, The American journal of medicine.

High levels of TH2 cytokine gene expression in systemic lupus erythematosus.

J. Alcocer-Varela, Y. Richaud-Patin, L. Llorente, 1995, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

A defect in immunoregulatory synovial fluid T cells in Behcet's syndrome

D. Alarcón-Segovia, C. Abud-Mendoza, A. Laffón, 1989, Clinical Rheumatology.

Some patients with primary antiphospholipid syndrome have increased circulating CD5+ B cells that correlate with levels of IgM antiphospholipid antibodies.

J. Sánchez-Guerrero, D. Alarcón-Segovia, J. Alcocer-Varela, 1991, Clinical and experimental rheumatology.

Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.

J. Sánchez-Guerrero, J. Simón, E. Ortíz, 2003, Rheumatology.

Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro‐apoptotic subsets

J. Alcocer-Varela, D. Gómez-Martín, P. Villaseñor-Ovies, 2015, Clinical and experimental immunology.

Interleukin-1 and Interleukin-6 Activities are Increased in the Cerebrospinal Fluid of Patients with CNS Lupus Erythematosus and Correlate with Local Late T-Cell Activation Markers

D. Alarcón-Segovia, J. Alcocer-Varela, D. Aleman-Hoey, 1992, Lupus.

Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma.

D. Alarcón-Segovia, J. Alcocer-Varela, E. Martínez‐Cordero, 1985, Clinical and experimental immunology.

Art and rheumatology: the artist and the rheumatologist's perspective.

A. Hinojosa-Azaola, J. Alcocer‐Varela, 2014, Rheumatology.

Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus.

J. Terwilliger, R. Jonsson, A. Bolstad, 2000, Genomics.

Natural killer cell activity in dermatomyositis-polymyositis.

R. González-Amaro, D. Alarcón-Segovia, J. Alcocer-Varela, 1987, The Journal of rheumatology.

Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case–control study

J. Alcocer-Varela, A. Arauz, M. Martínez-Martínez, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome

J. Alcocer-Varela, A. Arauz, J. Merayo-Chalico, 2018, Clinical and experimental immunology.

Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population

R. González-Amaro, J. Alcocer-Varela, D. Gómez-Martín, 2014, Clinical and experimental immunology.

IRF 3 and interferon signature on pDC in SLE

R. González-Amaro, J. Alcocer-Varela, D. Gómez-Martín, 2014 .

CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance.

J. Alcocer-Varela, D. Gómez-Martín, J. Romo-Tena, 2013, Autoimmunity reviews.

Main role of cytokines in autoimmunity.

J. Alcocer-Varela, J. Alcocer‐Varela, 2001, The Israel Medical Association journal : IMAJ.

Cytokine gene expression in cirrhotic and non-cirrhotic human liver.

J. Alcocer-Varela, L. Llorent, Y. Richaud-Patin, 1996, Journal of hepatology.

The Systemic Lupus Erythematosus Infection Predictive Index (LIPI): A Clinical-Immunological Tool to Predict Infections in Lupus Patients

J. Alcocer-Varela, J. Merayo-Chalico, A. Barrera-Vargas, 2019, Front. Immunol..

Factors Associated with Mortality and Infections in Patients with Systemic Lupus Erythematosus with Diffuse Alveolar Hemorrhage

J. Alcocer-Varela, A. Sturbaum, M. Martínez-Martínez, 2014, The Journal of Rheumatology.

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Mexican Population: Clinical Phenotype, Autoantibody Profile and Renal Characteristics

J. Alcocer-Varela, C. Uriarte-Hernández, C. Nuñez-Alvarez, 2016 .

Localized, single-organ vasculitis: clinical presentation and management

J. Alcocer-Varela, Y. Atisha‐Fregoso, A. Hinojosa-Azaola, 2012, Clinical Rheumatology.

Ro52/TRIM21‐deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies

J. Alcocer-Varela, J. Merayo-Chalico, A. Barrera-Vargas, 2017, Clinical and experimental immunology.

IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus.

R. González-Amaro, J. Alcocer-Varela, H. de la Fuente, 2005, Rheumatology.

Genetic analysis of the contribution of IL10 to systemic lupus erythematosus.

U. Gyllensten, L. Klareskog, L. Truedsson, 1999, The Journal of rheumatology.

Differential interleukin (IL)-10 and IL-13 gene expression in vivo in salivary glands and peripheral blood mononuclear cells from patients with primary Sjögren's syndrome.

J. Alcocer-Varela, L. Llorente, G. Villarreal, 1996, Immunology letters.

The mechanism of action of L-canavanine in inducing autoimmune phenomena.

D. Alarcón-Segovia, J. Alcocer-Varela, J. Alcocer‐Varela, 1985 .

Elevated Th1 cytokine mRNA in skin biopsies and peripheral circulation in patients with erythema nodosum.

Y. Richaud-Patin, R. Orozco‐Topete, E. Reyes, 1997, European cytokine network.

Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities.

J. Alcocer-Varela, M. Diaz-Zamudio, D. Gómez-Martín, 2009, Autoimmunity reviews.

Comparison of the Impacts of a Dynamic Exercise Program vs. a Mediterranean Diet on Serum Cytokine Concentrations in Women With Rheumatoid Arthritis. A Secondary Analysis of a Randomized Clinical Trial

J. Alcocer-Varela, L. Castillo-Martínez, Mariel Lozada-Mellado, 2022, Frontiers in Nutrition.

Changes in hand grip strength and body weight after a dynamic exercise program and Mediterranean diet in women with rheumatoid arthritis: a randomized clinical trial

J. Alcocer-Varela, L. Castillo-Martínez, A. Orea-Tejeda, 2020, Physiotherapy theory and practice.

Effect of a Dynamic Exercise Program in Combination With Mediterranean Diet on Quality of Life in Women With Rheumatoid Arthritis.

J. Alcocer-Varela, L. Castillo-Martínez, Mariel Lozada-Mellado, 2019, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Effect of pregnancy on functions of circulating T cells from patients with systemic lupus erythematosus: correction of T-cell suppression and autologous mixed-lymphocyte responses.

D. Alarcón-Segovia, J. Alcocer-Varela, E. Díaz-Jouanen, 1983, Clinical immunology and immunopathology.

Body composition evaluated by body mass index and bioelectrical impedance vector analysis in women with rheumatoid arthritis.

J. Alcocer-Varela, L. Castillo-Martínez, A. Orea-Tejeda, 2018, Nutrition.

Constitutive STAT3 activation in peripheral CD3+ cells from patients with primary Sjögren's syndrome

J. Alcocer-Varela, G. Valencia-Pacheco, J. Alcocer‐Varela, 2008, Scandinavian journal of rheumatology.

Clinical, histopathological, immunological and fibroblast studies in 30 patients with subcutaneous injections of modelants including silicone and mineral oils.

D. Alarcón-Segovia, J. Alcocer-Varela, R. Orozco‐Topete, 1994, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum?: a case control study.

J. Alcocer-Varela, J. Merayo-Chalico, A. Barrera-Vargas, 2014, Thrombosis research.

Immunogenetics of mixed connective tissue disease in a Mexican Mestizo population.

D. Alarcón-Segovia, J. Alcocer-Varela, J. Granados, 1999, Clinical and experimental rheumatology.

Factors associated with fetal losses in severe systemic lupus erythematosus

D. Alarcón-Segovia, J. Alcocer-Varela, C. Arce-Salinas, 1996, Lupus.

Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity.

J. Alcocer-Varela, M. Diaz-Zamudio, D. Gómez-Martín, 2010, Autoimmunity reviews.

Renal Thrombotic Microangiopathy in Proliferative Lupus Nephritis: Risk Factors and Clinical Outcomes A Case-Control Study

J. Alcocer-Varela, J. Merayo-Chalico, A. Barrera-Vargas, 2016, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Collagen turnover is diminished by different clones of skin fibroblasts from early- but not late-stage systemic sclerosis

J. Alcocer-Varela, L. Díaz de León, E. Krötzsch, 2004, Rheumatology International.

Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial.

J. Alcocer-Varela, A. Cabral, M. Zapata-Zúñiga, 2003, The Journal of rheumatology.

Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. Correlation with proliferative responses and production of IL-2.

F. Sánchez‐Madrid, D. Alarcón-Segovia, J. Alcocer-Varela, 1991, Journal of autoimmunity.

Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape

J. Alcocer-Varela, M. Martínez-Martínez, C. García-García, 2019, The Journal of Rheumatology.

Total Hip Arthroplasty Outcomes: An 18-Year Experience in a Single Center: Is Systemic Lupus Erythematosus a Potential Risk Factor for Adverse Outcomes?

J. Alcocer-Varela, J. Merayo-Chalico, D. Gómez-Martín, 2017, The Journal of arthroplasty.

The role of low density granulocytes and NETosis in the pathogenesis of adult-onset Still's Disease.

J. Alcocer-Varela, J. Torres-Ruiz, M. Tapia-Rodríguez, 2019, Clinical and experimental rheumatology.

Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE)

D. Alarcón-Segovia, J. Alcocer-Varela, J. Granados, 1997, Lupus.

Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study.

J. Alcocer-Varela, J. Merayo-Chalico, D. Gómez-Martín, 2013, QJM : monthly journal of the Association of Physicians.

Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematocus

D. Alarcón-Segovia, J. Alcocer-Varela, J. Alcocer‐Varela, 2004, Rheumatology International.

Collagen‐PVP Decreases Collagen Turnover in Synovial Tissue Cultures from Rheumatoid Arthritis Patients

J. Alcocer-Varela, L. Díaz de León, J. Furuzawa-Carballeda, 1999, Annals of the New York Academy of Sciences.

Factors associated with remission in patients with systemic lupus erythematosus: new insights into a desirable state

J. Alcocer-Varela, R. R. Garza, D. Gómez-Martín, 2018, Clinical Rheumatology.

Contamination with Mycoplasma spp. induces interleukin-13 expression by human skin fibroblasts in culture.

C. Zurita-Salinas, A. Palacios-Boix, A. Yáñez, 1996, FEMS immunology and medical microbiology.

Polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. Effect of intramuscular administration in a double blind placebo-controlled clinical trial.

J. Alcocer-Varela, J. Furuzawa-Carballeda, R. Fenutria-Ausmequet, 2006, Clinical and experimental rheumatology.

Immunoregulatory defects in juvenile rheumatoid arthritis. Comparison between patients with the systemic or polyarticular forms.

D. Alarcón-Segovia, R. Burgos-Vargas, M. Alarcón‐Riquelme, 1988, Journal of Rheumatology.

Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome

J. Alcocer-Varela, J. Rojas-Serrano, J. Simón, 2004, Lupus.

Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case-control study.

J. Alcocer-Varela, J. Merayo-Chalico, A. Barrera-Vargas, 2015, Rheumatology.

Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study

D. Alarcón-Segovia, J. Alcocer-Varela, M. Cardiel, 1995, Lupus.

Casitas B lineage lymphoma b is a key regulator of peripheral tolerance in systemic lupus erythematosus.

J. Alcocer-Varela, M. Diaz-Zamudio, D. Gómez-Martín, 2013, Arthritis and rheumatism.

Risk Factors for Drug-resistant Bloodstream Infections in Patients with Systemic Lupus Erythematosus

J. Alcocer-Varela, J. Merayo-Chalico, A. Barrera-Vargas, 2014, The Journal of Rheumatology.

FRI0184 SAFETY AND EFFICACY OF SPLENECTOMY IN THE TREATMENT OF ANTIPHOSPHOLIPID SYNDROME-ASSOCIATED CYTOPENIAS

J. Merayo-Chalico, A. Barrera-Vargas, Samuel Govea-Peláez, 2019, Poster Presentations.

Development, recurrence, and severity of infections in Mexican patients with rheumatoid arthritis. A nested case-control study.

J. Alcocer-Varela, A. Villa, M. Cardiel, 1998, The Journal of rheumatology.

Immunoregulatory defects in patients with systemic lupus erythematosus in clinical remission

D. Alarcón-Segovia, J. Alcocer-Varela, Y. Richaud-Patin, 2003, Lupus.

Purified protein derivative reaction in systemic lupus erythematosus patients. Indirect study of cellular immunity

J. Alcocer-Varela, J. Sifuentes-Osornio, V. Pascual-Ramos, 2002, Lupus.

Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa.

D. Alarcón-Segovia, J. Alcocer-Varela, L. Llorente, 1985, Arthritis and rheumatism.

A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups.

G. Sturfelt, U. Gyllensten, L. Klareskog, 1999, Journal of autoimmunity.

Probable depiction of juvenile arthritis by Sandro Botticelli.

D. Alarcón-Segovia, J. Alcocer-Varela, A. Laffón, 1983, Arthritis and rheumatism.

Immunoregulatory T cells in autoimmunity.

J. Alcocer-Varela, J. Alcocer‐Varela, J. Crispín, 2004, Autoimmunity reviews.

Defective expression and function of the ILT2/CD85j regulatory receptor in dendritic cells from patients with systemic lupus erythematosus.

R. González-Amaro, J. Alcocer-Varela, D. Gómez-Martín, 2013, Human immunology.

Mononuclear cell-fibroblast interactions in scleroderma.

R. González-Amaro, D. Alarcón-Segovia, J. Alcocer-Varela, 1988, Clinical immunology and immunopathology.

Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases

D. Alarcón-Segovia, J. Alcocer-Varela, A. Laffón, 2004, Rheumatology International.

Natural killer cell activity in the systemic connective tissue diseases.

R. González-Amaro, D. Alarcón-Segovia, J. Alcocer-Varela, 1988, The Journal of rheumatology.

Cytokine gene and CD25 antigen expression by peripheral blood T cells from patients with primary Sjögren's syndrome.

J. Alcocer-Varela, L. Llorente, G. Villarreal, 1995, Autoimmunity.

Association of HLA-DR5 (DR11) with systemic sclerosis (scleroderma) in Mexican patients.

D. Alarcón-Segovia, J. Granados, G. Vargas-Alarcón, 1995, Clinical and experimental rheumatology.

Description of a new HLA-B40 allele (B*4011) found in a Mexican individual of Nahua (Aztec) descent

J. Granados, A. Arnaiz-Villena, E. Gomez-Casado, 1997, Immunogenetics.

The connective tissue diseases as disorders of immune regulation.

D. Alarcón-Segovia, E. Díaz-Jouanen, J. Alcocer‐Varela, 1985, Clinics in rheumatic diseases.

Down‐Regulation–Resistant STAT4 Risk Haplotype Contributes to Lupus Nephritis Through CD4+ T Cell Interferon‐γ Production

M. Furlan-Magaril, J. Alcocer-Varela, I. Madera-Salcedo, 2022, Arthritis & rheumatology.